Table 2.
ED50 values and 95% confidence limits for drugs to decrease rate of operant responding (Response Rate) and rectal temperature (Temperature) before, during, and after discontinuation of daily Δ9-THC (32 mg/kg) treatment
| ED50 in mg/kg (95% confidence limits) | Potency ratioa (95% confidence limits) | |
|---|---|---|
| Δ9-THC response rate | ||
| Before | 5.64 (3.52–9.03) | |
| During | 46b (3.7–570) | 8.2 (1.4–48) |
| After | 17.9b (7.23–44.5) | 3.2 (1.4–7.5) |
| Δ9-THC temperature | ||
| Before | 10.2 (7.06–14.8) | |
| During | c | |
| After | 23.0b (15.8–33.5) | 2.3 (1.4–3.7) |
| CP 55940 response rate | ||
| Before | 0.12 (0.069–0.21) | |
| During | 0.20 (0.11–0.35) | 1.7 (0.8–3.5) |
| After | 0.17 (0.049–0.60) | 1.4 (0.5–4.1) |
| CP 55940 temperature | ||
| Before | 0.48 (0.37–0.67) | |
| During | c | |
| After | 2.01b (1.26–3.18) | 4.2 (2.5–7.2) |
| Anandamide response rate | ||
| Before | 5.45 (3.42–8.69) | |
| During | 7.46 (3.23–17.2) | 1.4 (0.6–2.9) |
| After | 5.25 (3.32–8.31) | 1.0 (0.5–1.8) |
| Anandamide temperature | ||
| Before | 19.2 (15.3–24.2) | |
| During | 20.4 (14.7–28.4) | 1.1 (0.7–1.6) |
| After | 16.1 (12.4–20.7) | 0.8 (0.6–1.2) |
| Midazolam response rate | ||
| Before | 4.03 (2.54–6.41) | |
| During | 23.3 (13.1–41.3) | d |
| After | 4.37 (2.32–8.23) | 1.1 (0.5–2.2) |
| Midazolam temperature | ||
| Before | 11.0 (6.65–18.3) | |
| During | 22.4 (8.25–60.7) | 2.0 (0.8–5.4) |
| After | 9.77 (5.65–16.9) | 0.9 (0.4–1.8) |
Potency ratios and 95% confidence limits are ED50 values determined during or after discontinuation of Δ9-THC treatment divided by the ED50 value determined before Δ9-THC treatment
Significantly different from Before
ED50 value not determined; the largest dose did not produce greater than 50% effect
Potency ratio not calculated because slopes were significantly different